Home › Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA
 

Keywords :   


Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

2016-01-17 19:50:21| Biotech - Topix.net

Novartis announced today that the US Food and Drug Administration has approved Cosentyx for two new indications - the treatment of adult patients with active ankylosing spondylitis and active psoriatic arthritis . AS and PsA are both life-long, painful and debilitating inflammatory diseases that affect the joints and/or spine.

Tags: with treatment adult approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05China's Nio unveils Tesla Model Y rival
16.05Could the US economy be doing too well?
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
More »